A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection
暂无分享,去创建一个
J. Bertin | R. Maehr | J. Cruz | K. Parsi | K. Fitzgerald | Zhaozhao Jiang | Liraz Shmuel-Galia | F. Humphries | Ángel I. Morales-Ramos | Ruth Wilson | G. S. Pesiridis | Sze-Ling Ng | J. Ramanjulu | Philip Landis | Fiachra Humphries
[1] Emily M. Lee,et al. Pharmacological activation of STING blocks SARS-CoV-2 infection , 2021, Science Immunology.
[2] Wei Liu,et al. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection , 2021, Journal of Virology.
[3] Zhijian J. Chen,et al. TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections , 2021, Proceedings of the National Academy of Sciences.
[4] Shruti Sharma,et al. cGAS-STING Pathway Does Not Promote Autoimmunity in Murine Models of SLE , 2021, Frontiers in Immunology.
[5] D. Sachs,et al. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity , 2021, Immunity.
[6] Xiaoyu Pan,et al. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system , 2021, Antiviral Research.
[7] J. Mascola,et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.
[8] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.
[9] M. Carcaterra,et al. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory , 2020, Medical Hypotheses.
[10] Jacques Fellay,et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.
[11] Shamus P. Keeler,et al. SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function , 2020, Nature Immunology.
[12] A. Iwasaki,et al. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling , 2020, The Journal of experimental medicine.
[13] Moriah L. Szpara,et al. Interferon-independent STING signaling promotes resistance to HSV-1 in vivo , 2020, Nature Communications.
[14] Nan Yan,et al. Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion. , 2020, Immunity.
[15] Jennifer L. Bell,et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.
[16] Taylor M. Matte,et al. Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors , 2020, bioRxiv.
[17] Akiko Iwasaki,et al. Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19 , 2020, Cell Host & Microbe.
[18] Eric Song,et al. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling , 2020, bioRxiv.
[19] L. Dodd,et al. Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.
[20] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[21] M. Letko,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[22] Wenling Wang,et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice , 2020, Nature.
[23] Ralph S. Baric,et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.
[24] Ignacio S. Caballero,et al. Reconstructed Single-Cell Fate Trajectories Define Lineage Plasticity Windows during Differentiation of Human PSC-Derived Distal Lung Progenitors. , 2020, Cell stem cell.
[25] D. Kotton,et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells , 2019, Nature Protocols.
[26] Zhijian J. Chen,et al. Structural basis of STING binding with and phosphorylation by TBK1 , 2019, Nature.
[27] Zhijian J. Chen,et al. Autophagy Induction via STING Trafficking Is a Primordial Function of the cGAS Pathway , 2019, Nature.
[28] J. Bertin,et al. Design of amidobenzimidazole STING receptor agonists with systemic activity , 2018, Nature.
[29] R. Vance,et al. Tumor‐Derived cGAMP Triggers a STING‐Mediated Interferon Response in Non‐tumor Cells to Activate the NK Cell Response , 2018, Immunity.
[30] Zhijian J. Chen,et al. cGAS is essential for the antitumor effect of immune checkpoint blockade , 2017, Proceedings of the National Academy of Sciences.
[31] J. Nyengaard,et al. Sensing of HSV-1 by the cGAS–STING pathway in microglia orchestrates antiviral defence in the CNS , 2016, Nature Communications.
[32] George E. Katibah,et al. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. , 2015, Cell reports.
[33] Ying Wang,et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. , 2014, Immunity.
[34] Zhijian J. Chen,et al. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.
[35] R. Schreiber,et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors , 2011, The Journal of experimental medicine.
[36] K. Murphy,et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells , 2011, The Journal of experimental medicine.
[37] David K. Meyerholz,et al. Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus , 2006, Journal of Virology.
[38] Zhijian J. Chen,et al. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP–AMP , 2019, Nature.